Assignee profile:

Siga Technologies, Inc.

City:

Corvallis, Oregon

Country:

United States

Published Applications:

70

Last publication date:

2026-01-01

Patent Grants:

61

Last grant date:

2025-10-07

Top Inventors for applications by Siga Technologies, Inc.

These are the the leading inventors for applications assigned to Siga Technologies, Inc.:

Recent patent applications by Siga Technologies, Inc.

Siga Technologies, Inc. based in Corvallis, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-01-01
US20260000644A1
Human necessities

POLYMORPHIC FORMS OF ST-246 AND METHODS OF PREPARATION

#2 | 2024-05-16 ✅ Patent 12,433,868 granted on 2025-10-07
US20240156782A1
Human necessities

POLYMORPHIC FORMS OF ST-246 AND METHODS OF PREPARATION

#3 | 2023-01-19 ✅ Patent 11,779,566 granted on 2023-10-10
US20230016581A1
Human necessities

ST-246 (tecovirimat monohydrate) suspension formulations

#4 | 2021-07-15 ✅ Patent 11,433,051 granted on 2022-09-06
US20210212987A1
Human necessities

ST-246 (tecovirimat monohydrate) suspension formulations

#5 | 2021-05-13 ✅ Patent 11,890,270 granted on 2024-02-06
US20210137885A1
Human necessities

Polymorphic forms of ST-246 and methods of preparation

#6 | 2020-05-07 ✅ Patent 10,864,282 granted on 2020-12-15
US20200138974A1
Human necessities

ST-246 liquid formulations and methods

#7 | 2019-12-19 ✅ Patent 10,716,759 granted on 2020-07-21
US20190380966A1
Human necessities

Rehydration of micronized tecovirimat monohydrate

#8 | 2019-11-14 ✅ Patent 10,933,050 granted on 2021-03-02
US20190343799A1
Human necessities

Polymorphic forms of ST-246 and methods of preparation

#9 | 2019-03-14 ✅ Patent 10,662,155 granted on 2020-05-26
US20190077753A1
Chemistry; metallurgy

Methods of preparing tecovirimat

#10 | 2019-02-07 ✅ Patent 10,576,165 granted on 2020-03-03
US20190038767A1
Human necessities

ST-246 liquid formulations and methods

#11 | 2018-11-01 ✅ Patent 10,406,137 granted on 2019-09-10
US20180311213A1
Human necessities

Polymorphic forms of ST-246 and methods of preparation

#12 | 2018-10-18 ✅ Patent 10,155,723 granted on 2018-12-18
US20180297949A1
Chemistry; metallurgy

Methods of preparing tecovirimat

#13 | 2018-08-16
US20180228748A1
Human necessities

INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS

#14 | 2018-07-12 ✅ Patent 10,045,964 granted on 2018-08-14
US20180193308A1
Human necessities

Polymorphic forms of ST-246 and methods of preparation

#15 | 2018-07-05 ✅ Patent 10,124,071 granted on 2018-11-13
US20180185514A1
Human necessities

ST-246 liquid formulations and methods

#16 | 2018-05-10 ✅ Patent 10,045,963 granted on 2018-08-14
US20180125819A1
Human necessities

Amorphous Tecovirimat preparation

#17 | 2018-03-29 ✅ Patent 10,029,985 granted on 2018-07-24
US20180086705A1
Chemistry; metallurgy

Methods of preparing Tecovirimat

#18 | 2017-08-10 ✅ Patent 9,889,119 granted on 2018-02-13
US20170224661A1
Human necessities

Amorphous tecovirimat preparation

#19 | 2017-05-11 ✅ Patent 9,968,571 granted on 2018-05-15
US20170128393A1
Human necessities

Inhibitors and methods of inhibiting bacterial and viral pathogens

#20 | 2017-05-04
US20170121344A1
Chemistry; metallurgy

THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS

#21 | 2017-03-30 ✅ Patent 9,862,683 granted on 2018-01-09
US20170088517A1
Chemistry; metallurgy

Methods of preparing Tecovirimat

#22 | 2016-09-01
US20160250233A1
Human necessities

ANTIVIRAL DRUGS FOR TREATMENT OR PREVENTION OF DENGUE INFECTION

#23 | 2016-08-18 ✅ Patent 10,406,103 granted on 2019-09-10
US20160235676A1
Human necessities

Rehydration of micronized tecovirmimat monohydrate

#24 | 2016-06-02
US20160152635A1
Chemistry; metallurgy

THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS

#25 | 2016-06-02 ✅ Patent 9,670,158 granted on 2017-06-06
US20160152565A1
Chemistry; metallurgy

Amorphous tecovirimat preparation

#26 | 2016-04-21 ✅ Patent 9,744,154 granted on 2017-08-29
US20160107993A1
Chemistry; metallurgy

Polymorphic forms of ST-246 and methods of preparation

#27 | 2016-03-24 ✅ Patent 9,907,859 granted on 2018-03-06
US20160082128A1
Human necessities

ST-246 liquid formulations and methods

#28 | 2016-03-24 ✅ Patent 9,566,254 granted on 2017-02-14
US20160081950A1
Human necessities

Inhibitors and methods of inhibiting bacterial and viral pathogens

#29 | 2015-11-12 ✅ Patent 9,546,137 granted on 2017-01-17
US20150322010A1
Chemistry; metallurgy

Methods of preparing Tecovirimat

#30 | 2015-06-04
US20150150852A1
Human necessities

TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS

#31 | 2015-01-22 ✅ Patent 9,498,470 granted on 2016-11-22
US20150023916A1
Human necessities

Antiviral drugs for treatment of arenavirus infection

#32 | 2014-12-25 ✅ Patent 9,115,065 granted on 2015-08-25
US20140378681A1
Chemistry; metallurgy

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses

#33 | 2014-10-23 ✅ Patent 9,045,418 granted on 2015-06-02
US20140316145A1
Chemistry; metallurgy

Compounds, compositions and methods for treatment and prevention of infections and associated diseases

#34 | 2014-10-09
US20140301979A1
Chemistry; metallurgy

ANTI-ARENAVIRAL COMPOUNDS

#35 | 2014-09-18 ✅ Patent 9,067,873 granted on 2015-06-30
US20140275037A1
Chemistry; metallurgy

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

#36 | 2014-08-28 ✅ Patent 9,096,597 granted on 2015-08-04
US20140243367A1
Chemistry; metallurgy

Antiviral drugs for treatment of Arenavirus infection

#37 | 2014-05-08 ✅ Patent 8,754,082 granted on 2014-06-17
US20140128426A1
Chemistry; metallurgy

Antiviral drugs for treatment of infection

#38 | 2014-04-10
US20140100245A1
Chemistry; metallurgy

Antiviral Drugs for Treatment of Arenvirus Infection

#39 | 2014-01-09 ✅ Patent 9,233,097 granted on 2016-01-12
US20140011854A1
Human necessities

ST-246 liquid formulations

#40 | 2013-12-26 ✅ Patent 8,802,714 granted on 2014-08-12
US20130345278A1
Human necessities

Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases

#41 | 2013-11-14 ✅ Patent 9,353,051 granted on 2016-05-31
US20130303491A1
Chemistry; metallurgy

Antiviral drugs for treatment or prevention of dengue infection

#42 | 2013-10-03 ✅ Patent 8,664,274 granted on 2014-03-04
US20130261087A1
Human necessities

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses

#43 | 2013-08-01 ✅ Patent 9,233,087 granted on 2016-01-12
US20130195796A1
Human necessities

Inhibitors and methods of inhibiting bacterial and viral pathogens

#44 | 2013-06-27 ✅ Patent 8,492,434 granted on 2013-07-23
US20130165493A1
Chemistry; metallurgy

Antiviral drugs for treatment of arenavirus infection

#45 | 2013-05-23
US20130129677A1
Chemistry; metallurgy

Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections

#46 | 2012-12-06 ✅ Patent 8,791,110 granted on 2014-07-29
US20120308519A1
Chemistry; metallurgy

Anti-arenaviral compounds

#47 | 2012-10-11 ✅ Patent 8,993,604 granted on 2015-03-31
US20120258079A1
Physics

Treatment and prevention of dengue virus infections

#48 | 2012-06-14 ✅ Patent 9,199,920 granted on 2015-12-01
US20120149751A1
Chemistry; metallurgy

Antiviral drugs for treatment of arenavirus infection

#49 | 2012-05-03 ✅ Patent 8,518,951 granted on 2013-08-27
US20120107276A1
Human necessities

Anti-arenaviral compounds

#50 | 2012-03-22 ✅ Patent 8,871,746 granted on 2014-10-28
US20120071447A1
Human necessities

Antiviral drugs for treatment of arenavirus infection

#51 | 2012-01-26 ✅ Patent 9,301,949 granted on 2016-04-05
US20120022046A1
Chemistry; metallurgy

Thienopyridine derivatives for the treatment and prevention of dengue virus infections

#52 | 2012-01-26 ✅ Patent 8,410,149 granted on 2013-04-02
US20120022027A1
Chemistry; metallurgy

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

#53 | 2012-01-26 ✅ Patent 8,530,509 granted on 2013-09-10
US20120020922A1
Chemistry; metallurgy

Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases

#54 | 2011-09-29 ✅ Patent 9,339,466 granted on 2016-05-17
US20110236434A1
Human necessities

Polymorphic forms of ST-246 and methods of preparation

#55 | 2011-07-14 ✅ Patent 8,629,170 granted on 2014-01-14
US20110172281A1
Chemistry; metallurgy

Anti-viral drugs for treatment of arenavirus infection

#56 | 2011-06-30 ✅ Patent 9,029,376 granted on 2015-05-12
US20110158940A1
Human necessities

Small molecule inhibitors for the treatment or prevention of dengue virus infection

#57 | 2011-05-19 ✅ Patent 8,658,697 granted on 2014-02-25
US20110118505A1
Human necessities

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

#58 | 2011-03-17 ✅ Patent 8,461,177 granted on 2013-06-11
US20110064693A1
Chemistry; metallurgy

Antiviral drugs for treatment of arenavirus infection

#59 | 2011-02-03 ✅ Patent 8,623,347 granted on 2014-01-07
US20110027227A1
Chemistry; metallurgy

Antiviral drugs for treatment of arenavirus infection

#60 | 2011-01-13 ✅ Patent 8,124,643 granted on 2012-02-28
US20110009456A1
Human necessities

Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases

#61 | 2010-09-09 ✅ Patent 7,956,197 granted on 2011-06-07
US20100227892A1
Human necessities

Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases

#62 | 2010-07-29 ✅ Patent 8,518,960 granted on 2013-08-27
US20100189685A1
Human necessities

Antiviral drugs for treatment or prevention of dengue infection

#63 | 2009-08-13 ✅ Patent 8,642,596 granted on 2014-02-04
US20090203675A1
Chemistry; metallurgy

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses

#64 | 2009-07-16 ✅ Patent 8,106,058 granted on 2012-01-31
US20090180980A1
Human necessities

Anti-arenaviral compounds

#65 | 2009-02-05 ✅ Patent 8,148,428 granted on 2012-04-03
US20090036513A1
Chemistry; metallurgy

Antiviral drugs for treatment of arenavirus infection

#66 | 2008-05-01 ✅ Patent 7,737,168 granted on 2010-06-15
US20080103181A9
Human necessities

Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases

#67 | 2008-01-03 ✅ Patent 7,687,641 granted on 2010-03-30
US20080004452A1
Chemistry; metallurgy

Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases

#68 | 2007-12-13 ✅ Patent 8,039,504 granted on 2011-10-18
US20070287735A1
Chemistry; metallurgy

Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases

#69 | 2007-11-01 ✅ Patent 7,872,037 granted on 2011-01-18
US20070254934A1
Chemistry; metallurgy

Antiviral drugs for treatment of arenavirus infection

#70 | 2006-10-19 ✅ Patent 7,737,168 granted on 2010-06-15
US20060235051A1
Human necessities

Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases

Also check out SIGA TECHNOLOGIES, INC.'s (Corvallis, United States) applicant profile with 27 patent applications submitted.

AssigneeID:

23955 ⎘